Cargando…
Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule
Adenoviral vectors are being developed as vaccines against infectious agents and tumour-associated antigens, because of their ability to induce cellular immunity. However, the protection afforded in animal models has not easily translated into primates and clinical trials, underlying the need for im...
Autores principales: | Rollier, Christine S., Spencer, Alexandra J., Sogaard, Karen Colbjorn, Honeycutt, Jared, Furze, Julie, Bregu, Migena, Gilbert, Sarah C., Wyllie, David, Hill, Adrian V. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109070/ https://www.ncbi.nlm.nih.gov/pubmed/32235848 http://dx.doi.org/10.1038/s41598-020-61730-8 |
Ejemplares similares
-
Fusion of the Mycobacterium tuberculosis Antigen 85A to an Oligomerization Domain Enhances Its Immunogenicity in Both Mice and Non-Human Primates
por: Spencer, Alexandra J., et al.
Publicado: (2012) -
4-1BBL Enhances CD8(+) T Cell Responses Induced by Vectored Vaccines in Mice but Fails to Improve Immunogenicity in Rhesus Macaques
por: Spencer, Alexandra J., et al.
Publicado: (2014) -
Identification of 34 Novel Proinflammatory Proteins in a Genome-Wide Macrophage Functional Screen
por: Wyllie, David H., et al.
Publicado: (2012) -
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
por: Warimwe, George M, et al.
Publicado: (2013) -
Accelerating vaccine development and deployment: report of a Royal Society satellite meeting
por: Bregu, Migena, et al.
Publicado: (2011)